PRESS RELEASE
UNAIDS
13 July 2011 l Geneva
The results and data from studies in Kenya, Uganda and Botswana disclose that a daily antiretroviral tablet taken by people without HIV infection can reduce their risk of acquiring HIV by up to 73%. Both daily tenofovir and daily tenofovir/ emtricitabine taken as preventive medicine can avert heterosexual transmission of HIV from men to women, and vice versa.
“This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,” said Michel Sidibé, Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS).
Read the full story: http://www.unicmanila.org/main/index.php?pg=news&id=577
Share this Post[?]
Social Media